How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Susvimo cost savings if eligible
The Susvimo patient assistance program can provide your medication for free. We simply charge $49 per month for each medication to cover the cost of our services. With NiceRx, you will only pay $49 to obtain your Susvimo, regardless of the retail price.
Am I eligible for the Susvimo patient assistance program?
To find out if you are eligible for Susvimo assistance you can apply online using our enrollment application. Each pharmaceutical company sets its eligibility criteria, and we will review your application individually to determine if you may be eligible. The three main factors to consider are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Susvimo patient assistance program?
Our application process aims to make it as easy as possible to apply for the Susvimo patient assistance program. The first step is to complete our online enrollment application. We will ask you for details about your healthcare provider, your insurance plan, and your household income as this information is required by the pharmaceutical companies. We may be able to help you apply for other patient assistance programs too, so be sure to tell us about any medications you are taking as well as Susvimo.
NiceRx will review your application and determine whether you may be eligible for Susvimo assistance. If so, we will handle the full enrollment process for you and prepare all required documents for your healthcare provider to sign. Once you are successfully enrolled in the Susvimo patient assistance program, we will help you manage your prescription refills by requesting refills on your behalf throughout your enrollment period. At the end of your enrollment period, we will contact you for updated information and seek to re-enroll you so you can continue to access affordable Susvimo.
Is NiceRx a Susvimo coupon provider?
NiceRx is a service provider that helps eligible individuals access the Susvimo patient assistance program. We do not offer trial offers or free Susvimo samples. When obtaining your medication through NiceRx, you will only pay $49 a month per medication. This will likely save you more money than if you were to use Susvimo coupons, discount cards, or Susvimo copay cards.
Can NiceRx help me get Susvimo cheaper if I have insurance?
NiceRx may be able to help you if your insurance company will not pay for your Susvimo medication. We may also be able to help if you have a high copay or coinsurance responsibility. Whether you have insurance or not, apply online using our enrollment application to find out more.
How much does Susvimo cost without insurance?
Susvimo prices without insurance will vary depending on how much you buy. Prices will also vary by retailer. As a guide, Susvimo intravitreal solution (100 mg/mL) typically costs $8,400 for 0.1 milliliters.
How much does Susvimo cost with insurance?
The copay for Susvimo will vary by the terms of your healthcare plan. To find out what you might need to pay for Susvimo with insurance, your insurance provider or pharmacist will be able to help you calculate the copay costs with your current insurance.
What is Susvimo?
Susvimo is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Genentech, Inc. a member of the Roche Group. Susvimo is a vascular endothelial growth factor (VEGF) inhibitor, indicated for ophthalmic patients with Neovascular, wet Age-related Macular Degeneration (wet AMD) who have responded to at least two intravitreal injections of a VEGF inhibitor in the past.
The Susvimo implant is three times more likely to cause endophthalmitis than monthly intravitreal injections. 2.0% of patients receiving an implant experienced an episode of endophthalmitis in clinical trials.
What doses of Susvimo are available?
Susvimo is available in injection form, in the following doses: 100 mg/mL solution in a single-dose vial.
For intravitreal use via ocular implant, the recommended dose of Susvimo is 0.02 mL of 100 mg/mL solution via the Susvimo implant with refills every 24 weeks. Supplemental treatment with 0.5 mg intravitreal ranibizumab injection may be administered in the affected eye if required. Initial implantation, refill-exchange, and implant removal procedures are performed under strict aseptic conditions.
Please see the full prescribing information for the complete boxed warning and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Susvimo active ingredients
Susvimo contains ranibizumab, an anti-VEGF as the active ingredient.
Susvimo side effects
The most common side effects of Susvimo in clinical trials include:
- Conjunctival hemorrhage
- Conjunctival hyperemia
- Eye pain
In rare instances, Susvimo can cause more serious side effects. These can include:
- Endophthalmitis (eye infection) – symptoms include increasing eye pain, vision loss, sensitivity to light, or redness in the white of the eye. Call your healthcare provider right away if you have these symptoms
- Rhegmatogenous retinal detachment, implant dislocation, vitreous hemorrhage, conjunctival retraction, conjunctival erosion, and conjunctival bleb
- Vitreous hemorrhage
- Postoperative decrease in visual acuity
Your doctor will assess the benefits of using Susvimo against your risk of adverse events. Patients are encouraged to report negative side effects or adverse reactions of Susvimo to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Susvimo drug interactions
Other drugs may interact with Susvimo, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medication including any supplements you are taking.
You should not use Susvimo if you:
- Are allergic to the active ingredient ranibizumab
- Are allergic to any of the other ingredients in Susvimo
- Have ocular or periocular infections
- Have active intraocular inflammation
- Are pregnant or are planning to become pregnant
Talk to your doctor before using Susvimo if you:
- Are taking any of the medications that could interact with Susvimo
- Are breastfeeding or are planning to breastfeed
Susvimo is the trademark brand name for ranibizumab manufactured by Genentech, Inc. a member of the Roche Group. A generic version of ranibizumab is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Susvimo savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.